CD8A and neoplasm: While cDC1s are essential to antitumor immunity due to their unique ability to cross-present antigens to cytotoxic CD8+ T cells [61], their broader role during tumor development seems to be more complex, and a better understanding is needed to determine the optimal therapeutic window.